XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value of Financial Instruments
 3 Months Ended
Mar. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
The following tables show CRA's financial instruments recorded in the condensed consolidated financial statements which are measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands):
March 30, 2024
Level 1Level 2Level 3
Assets:
Money market mutual funds$— $— $— 
Total Assets$— $— $— 
Liabilities:
Contingent consideration liability$— $— $190 
Total Liabilities$— $— $190 
December 30, 2023
Level 1Level 2Level 3
Assets:
Money market mutual funds$— $— $— 
Total Assets$— $— $— 
Liabilities:
Contingent consideration liability$— $— $190 
Total Liabilities$— $— $190 
The contingent consideration liability pertains to estimated future contingent consideration payments related to the acquisition of bioStrategies Group, Inc. during fiscal 2022. The following table summarizes the changes in the contingent consideration liability (in thousands):
Fiscal Quarter EndedFiscal Year Ended
March 30, 2024December 30, 2023
Beginning balance$190 $1,056 
Remeasurement of acquisition-related contingent consideration— (934)
Accretion— 68 
Ending balance$190 $190